A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 12, 2010, Pages 1336-1340

  Martin, Fabiola ^a,b   Fedina, Alexandra ^a   Youshya, Silva ^b   Taylor, Graham P ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER FUNCTION; BREAST FEEDING; CAUSE OF DEATH; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INTESTINE FUNCTION; LEG PAIN; LOW BACK PAIN; MALE; MORTALITY; PATIENT MOBILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINAL CORD DISEASE; UNITED KINGDOM; UNSAFE SEX; VIRUS INFECTION; VIRUS LOAD; WALKING AID; WHEELCHAIR;

EID: 78649576456     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.191239     Document Type: Article

References (30)

1. Cruickshank JK, Rudge P, Dalgleish AG, et al. Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain 1989;112:1057-90. (Pubitemid 19199484)
2. Orland JR, Engstrom J, Fridey J, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV outcomes study. Neurology 2003;61:1588-94.
3. Franzoi AC, Araujo AQ. Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM). Spinal Cord 2005;43:236-40.
4. Olindo S, Cabre P, Lézin A, et al. Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 2006;63:1560-6.
5. Lee H, Anderson E, Allain JP, et al. HTLV-1 infection in Brazil. Blood 1989;73:1742.
6. Moreira ED Jr, Ribeiro TT, Swanson P, et al. Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil. J Acquir Immune Defic Syndr 1993;6:959-63.
7. dos Santos JI, Lopes MA, Deliège-Vasconcelos E, et al. Seroprevalence of HIV, HTLV-I/II and other perinatally-transmitted pathogens in Salvador, Bahia. Rev Inst Med Trop Sao Paulo 1995;37:343-8.
8. Sanders RC, Wai'in PM, Alexander SS, et al. The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea. Arch Virol 1993;130:327-34.
9. Safai B, Huang JL, Boeri E, et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses 1996;12:1185-90.
10. Abbaszadegan MR, Gholamin M, Tabatabaee A, et al. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol 2003;41:2593-5.
11. Gastaldello R, Hall WW, Gallego S. Seroepidemiology of HTLV-I/II in Argentina: an overview. J Acquir Immune Defic Syndr 2004;35:301-8.
12. Sarkodie F, Adarkwa M, Adu-Sarkodie Y, et al. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang 2001;80:142-7.
13. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991;133:1114-24.
14. Mueller N, Okayama A, Stuver S, et al. Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S2-7.
15. Yamaguchi K. Human T-lymphotropic virus type I in Japan. Lancet 1994;343:213-16. (Pubitemid 24031646)
16. De Castro-Costa CM, Araújo AQ, Barreto MM, et al. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS Res Hum Retroviruses 2006;22:931-5.
17. Araujo AQ, Leite AC, Dultra SV, et al. Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 1995;129:147-51.
18. Roman GC, Roman LN. Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome. J Neurol Sci 1988;87:121-38.
19. Vernant JC, Maurs L, Gessain A, et al. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol 1987;21:123-30.
20. Montgomery RD, Cruickshank EK, Robertson WB, et al. Clinical and pathological observations on Jamaican neuropathy: a report on 206 cases. Brain 1964;87:425-62.
21. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol 2001;7:228-34.
22. Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995;1:50-61.
23. Bittencourt AL, Primo J, Oliveira MF. Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence. J Pediatr (Rio J) 2006;82:411-20.
24. Lima MA, Harab RC, Schor D, et al. Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 2007;13:468-73.
25. Gotuzzo E, Cabrera J, Deza L, et al. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 2004;39:939-44.
26. Tosswill JHC, Taylor GP, Tedder RS, et al. HTLV-I-associated disease in England and Wales 1993-7: a retrospective study of serology requests. BMJ 1999;320:611-12.
27. Taylor GP, Goon P, Furukawa Y, et al. Zidovudine plus lamivudine in Human T-Lymphotropic virus type-I-associated myelopathy: a randomised trial. Retrovirology 2006;3:63.
28. Goon PK, Igakura T, Hanon E, et al. HTLV-I specific CD4+ T cells: Immunodominance hierarchy and preferential infection with HTLV-I. J Immunol 2004;172:1735-43.
29. Arisawa K, Sobue T, Yoshimi I, et al. Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study. Cancer Causes Control 2003;14:889-96.
30. Holmgren B, da Silva Z, Vastrup P, et al. Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 2007;4:85.